ENTITY
Glaxosmithkline Pharmaceuticals

Glaxosmithkline Pharmaceuticals (GLXO IN)

29
Analysis
Health Care • India
Glaxosmithkline Pharmaceuticals Ltd. manufactures and distributes a wide variety of pharmaceutical drugs, veterinary products and laboratory chemicals. The Company's products include "Phexin" capsules, "Betnesol" tablets and injections, "Becoride" asthma treatment, "Betnovate" ointment, "Cetzine" antihistamine, "Zucox" and "Rizap" anti-tuberculosis products.
more
bullish•Mankind Pharma
•19 Apr 2023 12:18

Mankind Pharma IPO - Quality Name but Might Not Have a Whole Lot of Upside

Mankind Pharma (MP) is looking to raise up to US$527m in its upcoming India IPO. In this note, we talk about the implied valuations.

Logo
581 Views
Share
bullish•Indegene
•19 Apr 2023 10:51

Indegene Pre-IPO - Growing Client Base and Cross/Up-Selling Led to Growth

Indegene Limited (1864095D IN) is looking to raise about US$400m in its upcoming India IPO. Indegene is a “digital-first” commercialisation firm...

Logo
649 Views
Share
bullish•Mankind Pharma
•18 Apr 2023 17:04

Mankind Pharma Pre-IPO - RHP Updates - A Mixed Bag

Mankind Pharma  (MP) is now looking to raise around US$500m in its upcoming India IPO. In this note we talk about the updates from its recently...

Logo
425 Views
Share
bullish•Honasa Consumer
•21 Feb 2023 09:51

Honasa Consumer Pre-IPO - The Positives - New Age DTC Brand

Honasa Consumer, a DTC beauty and personal care brand, is looking to raise about US$350m in its upcoming India IPO. In this note, we will talk...

Logo
538 Views
Share
bullish•Mankind Pharma
•09 Feb 2023 10:55

Mankind Pharma Pre-IPO - Thoughts on Valuations

Mankind Pharma  is looking to raise about US$1bn in its upcoming India IPO. In this note, we will talk about valuations.

Logo
569 Views
Share
x